Is IVVD Worth Buying in 2026?

Invivyd, Inc. Common Stock

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-08-23

Here’s whether Invivyd, Inc. Common Stock (IVVD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: above the 50-day MA (medium-term momentum positive); strong 1-year return of +88.8%. Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-6.67% over 10 days); RSI 82 — overbought, elevated pullback risk; 3-month momentum negative (-9.4%); rising volume on a downtrend (distribution, 1.20x avg). Currently 67.5% off its 52-week high. Score: -3/7.

Ready to act on this? 📈 Trade on Webull

IVVD is trading below its 200-day MA ($1.54) — a key warning sign the longer-term trend is under pressure. With an RSI of 82.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +88.8% compares to +20.5% for SPY (beat the market by 68.3%). The current 67.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $18,877 today
vs. S&P 500 (SPY) — same period beat market by 68.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.54)
Above 50-day MA ($0.77)
!RSI(14) neutral zone (30–70) — currently 82.3
Positive return (+88.8%)
!Within 10% of period high (−67.5%)
Period Range $1.00
$0.48 $3.07
RSI (14) 82.3
0 · OversoldOverbought · 100

Key Metrics

Price$1.00
Period Return+88.8%
Period High$3.07
Period Low$0.48
Drawdown−67.5%
MA-50$0.77
MA-200$1.54
RSI (14)82.3
Avg Volume (30d)3.4M
vs. SPYbeat by 68.3%
Return Rank#141 of 999

Trade IVVD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers